Scholars Central

Conference abstractPublished 20 Oct 2014

Nucleoplasmic calcium arising as a new targeting to treat epithelial cancers

Authors: Lídia Maria de Andrade

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Conventional cancer therapies have been shown lower overall survival especially to treat epithelial tumors which has encouraged researchers worldwide to search for new approaches that could be able to improve chemotherapy effects as well as radiotherapy. In this scenario the main challenge is to find one method with higher selectivity to tumor cells rather than normal tissues avoiding severe sequels. This lecture will address the role of nucleoplasmic calcium as a potential new therapeutically cancer targeting to impair tumor cell proliferation and migration. Our research group already demonstrated that nuclear calcium buffering decreases tumor hepatic cell proliferation in vitro as well as in vivo through mitosis blocking even as the asparaginyl endo peptidase legumain expression reduction. Recently, we found the action of nuclear calcium buffering in the prevention of a disintegrin and metalloproteinase (ADAM-17) and epidermal growth factor receptor (EGFR) overexpression induced by ionizing radiation on human squamous cell carcinoma. Moreover, association of nuclear calcium buffering and X-rays is able to decrease survival fractions in 90%. Likewise, proliferation rate also decreased under nuclear calcium buffering in squamous cell carcinoma, without alteration on non-tumorigenic cells.In addition to these subjects, attendees of this lecture will be familiarized with the importance of calcium signaling patterns to cellular physiology and the proposal of nucleoplasmic calcium as a promising new targeting to epithelial cancer even as an adjuvant method to improve the beneficial radiotherapy effects.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Lídia Maria de Andrade”